share_log

Candel Therapeutics Receives Orphan Drug Designation From European Medicines Agency For CAN-2409 In Glioma

Candel Therapeutics Receives Orphan Drug Designation From European Medicines Agency For CAN-2409 In Glioma

Candel Treateutics获得欧洲药品管理局指定的治疗脑胶质瘤CAN-2409的孤儿药物
Benzinga Real-time News ·  2022/09/15 08:07

Candel Therapeutics Receives Orphan Drug Designation From European Medicines Agency For CAN-2409 In Glioma

Candel Treateutics获得欧洲药品管理局指定的治疗脑胶质瘤CAN-2409的孤儿药物

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发